You are here

immunotherapy

Incyte and Syndax's immunotherapy for transplant complications receives FDA approval

Biopharma Reporter

Tue, 08/20/24 - 11:49 am

graft vs host disease

Could pharma’s blockbuster immunotherapies work in dogs?

Pharma Voice

Thu, 07/11/24 - 11:16 am

ImmunityBio bags FDA approval for Anktiva to challenge Merck in bladder cancer

Fierce Pharma

Tue, 04/23/24 - 10:32 am

Patrick Soon-Shiong

Gilead bets on Xilio cancer drug as biotech restructures

BioPharma Dive

Thu, 03/28/24 - 11:54 am

Gilead Sciences

Xilio Therapeutics

Merck, Others Look to Immunotherapy Combos as Next Frontier in Oncology

BioSpace

Mon, 03/25/24 - 11:32 am

Astellas strikes $1.7bn SIRP drug deal with Elpiscience

Pharmaphorum

Tue, 01/2/24 - 09:56 am

Cidara’s J&J-partnered immunotherapy could target flu and cancer

Pharma Voice

Thu, 10/26/23 - 10:35 am

drug-Fc conjugates

GSK beats Merck to first PD-1 approval in newly diagnosed endometrial cancer

Fierce Pharma

Mon, 07/31/23 - 09:59 pm

endometrial cancer

Sellas celebrates positive Phase I results in lung cancer

Clinical Trials Arena

Thu, 06/29/23 - 11:35 am

clinical trials

Prime and Cimeio form research alliance to develop genetic disease solution

Medical Device Network

Fri, 06/23/23 - 09:40 am

Cimeio Therapeutics

genetic diseases

Larkspur Biosciences Launches with $35.5 Million in Financing to Build the Next Precision Immunotherapies to Outsmart Cancer

Globe Newswire

Tue, 05/23/23 - 11:40 am

Larkspur Biosciences

Myeloid Therapeutics Announces $73 Million Financing to Advance mRNA-based Immunotherapy Pipeline

PR Newswire

Thu, 05/18/23 - 10:48 am

Myeloid Therapeutics

With new startup, immunotherapy pioneer Lieping Chen tries to turn ‘cold’ tumors ‘hot’

BioPharma Dive

Tue, 10/25/22 - 11:03 am

Harvard spinout Surge emerges with $26M to make immunotherapy part of cancer surgery

MedCity News

Fri, 10/21/22 - 10:42 am

Surge Therapeutics

Using Machine Learning to Predict Immunotherapy Response

Medical Devices and Diagnostics Industry

Wed, 07/13/22 - 08:20 pm

machine learning

immune checkpoint inhibitors

artificial intelligence

Appetite for allergies: Alladapt banks $119M to push immunotherapy through trials

Fierce Biotech

Thu, 06/23/22 - 10:43 am

Alladapt Immunotherapeutics

Bristol Myers triples-down on Immatics, bringing deal to $4.2B total biobucks

Fierce Biotech

Thu, 06/2/22 - 12:19 pm

Bristol Myers Squibb

Cancer biotech Pheast unveils $76M to expand immunotherapy’s menu to new targets

MedCity News

Wed, 04/27/22 - 10:51 am

Pheast Therapeutics

Bristol Myers scraps $2B Nektar partnership after trial failures

BioPharma Dive

Mon, 04/18/22 - 11:42 pm

Bristol Myers Squibb

Nektar Therapeutics

BriaCell advances preparatory work for new Bria-OTS™ breast cancer clinical trial

BioSpace

Thu, 04/7/22 - 10:39 am

Pages